LITT and Pembrolizumab in Recurrent Brain Metastasis
Stopped Sponsor terminated
Conditions
- Melanoma
- Non-small Cell Lung Carcinoma (NSCLC)
- Renal Cell Carcinoma (RCC)
- Small-cell Lung Cancer
- Head and Neck Squamous Cell Cancer
- Classical Hodgkin Lymphoma
- Primary Mediastinal Large B-Cell Lymphoma
- Urothelial Carcinoma
- Microsatellite Instability-High Cancer
- Gastric Cancer
- Esophageal Cancer
- Cervical Cancer
- Hepatocellular Carcinoma
- Merkel Cell Carcinoma
- Brain Metastases, Adult
Interventions
- COMBINATION_PRODUCT: LITT + Pembrolizumab
Sponsor
University of Florida
Collaborators